Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
106.45
+3.52 (3.42%)
May 8, 2026, 9:49 AM EDT - Market open

Mirum Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,4914,0991,9911,379709488
Market Cap Growth
232.90%105.94%44.32%94.55%45.34%-6.17%
Enterprise Value
6,2144,0332,0261,400558.49333.15
Last Close Price
106.4578.9941.3529.5219.5015.95
PE Ratio
--168.06-22.35-7.38-4.85-5.76
PS Ratio
11.027.865.917.409.2025.49
PB Ratio
25.8613.038.825.554.994.06
P/TBV Ratio
23.8312.608.714.854.674.02
P/FCF Ratio
-74.71213.30-19.41-5.89-3.67
P/OCF Ratio
-73.43192.79-19.44-5.90-3.67
EV/Sales Ratio
10.917.746.017.517.2517.41
EV/EBITDA Ratio
-1913.32-31.67-14.24-4.36-1.93
EV/EBIT Ratio
--182.20-23.13-12.83-4.26-1.92
EV/FCF Ratio
-73.50217.13-19.70-4.64-2.51
Debt / Equity Ratio
1.331.011.401.230.010.02
Debt / EBITDA Ratio
-0.42150.53-4.94-3.13-0.02-0.01
Debt / FCF Ratio
-1.865.7833.87-4.34-0.02-0.02
Net Debt / Equity Ratio
-0.27-0.210.160.09-1.05-1.28
Net Debt / EBITDA Ratio
0.08-31.32-0.56-0.221.170.89
Net Debt / FCF Ratio
0.38-1.203.83-0.311.241.16
Asset Turnover
0.660.690.510.370.240.07
Inventory Turnover
4.214.243.653.373.502.52
Quick Ratio
1.902.462.834.072.713.75
Current Ratio
2.092.673.104.452.943.91
Return on Equity (ROE)
-286.74%-8.65%-37.08%-83.65%-103.46%-57.47%
Return on Assets (ROA)
-92.03%-3.19%-13.46%-21.97%-38.70%-64.79%
Return on Invested Capital (ROIC)
-312.05%-9.33%-32.94%-53.21%-105.88%-382.54%
Return on Capital Employed (ROCE)
-126.91%-3.75%-15.87%-25.75%-48.58%-73.10%
Earnings Yield
-12.73%-0.60%-4.47%-13.55%-20.62%-17.37%
FCF Yield
-2.75%1.34%0.47%-5.15%-16.98%-27.22%
Buyback Yield / Dilution
-9.74%-5.63%-16.23%-20.31%-12.07%-20.08%
Total Shareholder Return
-9.74%-5.63%-16.23%-20.31%-12.07%-20.08%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q